| Literature DB >> 33603587 |
Moftah Alhagamhmad, Aisha Elarwah, Alia Alhassony, Shirin Alougly, Hamza Milad, Aziza Dehoam, Suliman Elbrgathy, Nuri Shembesh, Emhemed Mousa, Abdulhamid ElShiky.
Abstract
Clinical manifestations of valproic acid (VPA) toxicity can range from just mild confusion and drowsiness to serious encephalopathy, leading to depressed sensorium and even coma and death. The exact cause(s) of how VPA influences the integrity of brain function remains unknown. Nevertheless, several mechanisms have been postulated including a surge in the blood ammonia concentration. Valproic acid-induced hyperammonemic encephalopathy is a rare yet serious sequalae and that can lead to grave outcomes. We report a case of hyperammonemic encephalopathy with preserved liver function following a moderate VPA intoxication in a toddler, who was successfully managed conservatively. Additionally, we briefly discuss mechanistic basis of VPA toxicity and highlight some of the available potential therapies. Copyright. Pediatric Pharmacy Association. All rights reserved. For permissions, email: mhelms@pediatricpharmacy.org 2021.Entities:
Keywords: accidental ingestion; adverse effect; case report; encephalopathy; hyperammonemia; infant; valproic acid
Year: 2021 PMID: 33603587 PMCID: PMC7887879 DOI: 10.5863/1551-6776-26.2.210
Source DB: PubMed Journal: J Pediatr Pharmacol Ther ISSN: 1551-6776